• Home
  • Explore Fushilai

    About Fushilai

    History

    Qualifications & Honors

    Partners

    Markets
  • Products

    Dietary supplement

    API & Intermediate

    CDMO&CMO

    FDF
  • R&D
  • News

    Company News

    Industry information

    Information disclosure
  • Investor Relations
  • Contact Us

    Contact information

    Careers
    • Select Region/Language
    Current Position：Home > News> Information disclosure

    2021 Enterprise Quality Credit Report

    Writer： SEKSUN Release date：2022-08-02 View：1384

    2021 Enterprise Quality Credit Report


    Suzhou Fujilai Pharmaceutical Co., Ltd.


    March 2022


    1660359848732170.pdf


    Next
    No Data
    Service hotline
    (+86)512-5283 5990
    © Copyright 2022 Suzhou Fushilai Pharmaceutical Company Limited, Su ICP Bei No. 14033558-1  Technical support:PROSINT
    完美体育「中国大陆」官方网站 | 龙珠体育.(中国)官方登录入口 | 亚新官方网站_亚新(中国) | 星空体育·(china)官方网站 | 星空体育(中国)官方网站-XINGKONG SPORT | 完美体育(中国)有限公司官网 | 星空体育·(中国)官方网站·IOS/安卓通用版/手机平台APP下载 |